Metabolic Research Peptides • Somatotropic Research Peptides
Tesamorelin
$70.00$70.00
● In stock
Tesamorelin (TH9507) is a synthetic 44-amino-acid analog of growth hormone-releasing hormone (GHRH), with an N-terminal trans-3-hexenoyl modification (CAS 218949-48-5, MW ~5135.9). Supplied as a ≥99% HPLC-tested lyophilized powder — with a lot-specific third-party COA available before purchase — for in-vitro and laboratory research applications only. Research Use Only — not for human or veterinary use.
Compound Name
Tesamorelin
Synonyms
TH9507; (trans-3-hexenoyl)hGHRH(1-44) amide; GHRH analog
CAS Number
218949-48-5
Molecular Formula
C₂₂₁H₃₆₆N₇₂O₆₇S
Molecular Weight
~5135.9 g/mol (some sources 5195.9
Peptide Length
44 amino acids (synthetic)
Structure
Full human GHRH(1-44) sequence; N-terminal trans-3-hexenoic acid (hexenoyl) modification on Tyr-1; C-terminal amide
Research Target
GHRH receptor (GHRHR)
Compound Class
Synthetic N-acylated GHRH analog
Purity
≥99% (HPLC) — see lot COA
Identity
Confirmed by LC-MS
Appearance
White lyophilized powder
Solubility
Soluble in water / aqueous buffer
Available Sizes
5mg, 10mg
Storage (lyophilized)
-20°C, sealed, dark, dry
Storage (reconstituted)
2–8°C short-term; aliquot & freeze -20°C; avoid freeze-thaw
Synthesis
Solid-phase peptide synthesis (SPPS)
Testing Lab
Freedom Diagnostics
Test Methods
Purity by HPLC; identity by LC-MS
Shipped From
USA
Certificate of Analysis
Lot-specific COA available
Size
10mg
20mg
For laboratory research use only. Not for human or veterinary
consumption. This product should only be handled by qualified
professionals.
Product information
Tesamorelin (TH9507) is a synthetic analog of growth hormone-releasing hormone (GHRH) comprising the full 44-amino-acid sequence of human GHRH(1-44), modified at the N-terminus by attachment of a trans-3-hexenoic acid (hexenoyl) group to the tyrosine-1 residue. This N-terminal acylation protects the Ala-Asp dipeptide at positions 2–3 from dipeptidyl peptidase-IV (DPP-IV) cleavage — the primary degradation pathway of native GHRH — conferring enhanced stability while retaining the GHRH sequence. This product is supplied as a lyophilized powder in multiple sizes, synthesized by solid-phase peptide synthesis (SPPS) and characterized by HPLC (purity) and LC-MS (identity), with a lot-specific third-party Certificate of Analysis available before purchase. It is intended exclusively for in-vitro laboratory research and analytical applications. In the research literature, Tesamorelin is referenced as a reference GHRH analog used as a tool compound in the study of GHRH-receptor (GHRHR) signaling.